SRF Q4 and FY26: Margin-led earnings as Chemicals drives the mix

SRF Limited closed Q4 FY26 with a steady top line and stronger profitability, helped by a better mix and healthier operating leverage across businesses. Consolidated gross operating revenue rose to ₹4,615.2 crore, up 7.0 percent year on year. EBITDA grew faster at ₹1,176.8 crore, up 13.5 percent, taking the quarterly EBITDA margin to 25.5 percent from 24.0 percent a year ago. Profit after tax came in at ₹582.0 crore, up 10.6 percent, with PAT margin at 12.6 percent.

For the full year, the profit story was clearer than the revenue story. FY26 gross operating revenue increased 7.4 percent to ₹15,786.5 crore. But EBITDA rose 24.7 percent to ₹3,705.0 crore, lifting EBITDA margin to 23.5 percent from 20.2 percent. PAT climbed 46.7 percent to ₹1,835.2 crore, and PAT margin expanded to 11.6 percent from 8.5 percent. The improvement reflects a combination of stronger operating performance, lower interest costs, and a sharper earnings contribution from the Chemicals business.

One way to read SRF’s FY26 is that it delivered a reset on profitability after a softer FY25, without taking balance sheet risk. Net debt to equity stood at 0.27 in FY26 versus 0.28 in FY25. Net debt to EBITDA improved to 1.02 from 1.19. With capex underway in Fluorochemicals and a recalibration in Films, the year also shows management’s preference for being selective on timing when industry cycles change.

FY26 in one page: growth, margins, and capital discipline

At a group level, SRF’s earnings mix continued to tilt towards Chemicals. In FY26, Chemicals contributed 49.3 percent of revenue and 75.2 percent of EBIT. Performance Films and Foil was 36.5 percent of revenue and 16.9 percent of EBIT. Technical Textiles, while smaller, remained meaningful at 11.9 percent of revenue and 6.3 percent of EBIT.

Q4 showed a similar pattern. Chemicals remained the core, but there was also a visible recovery in Films and an improvement in Technical Textiles margins. This matters because it reduces dependence on a single segment for incremental earnings, even as Chemicals remains the engine.

The company’s longer-range ratio table also hints at a return to more normal profitability. EBITDA margin improved to 23.47 percent in FY26 from 20.22 percent in FY25, while PAT margin improved to 11.63 percent from 8.51 percent. Interest cost fell sharply, with FY26 interest at ₹278.0 crore versus ₹376.0 crore in FY25, supporting net profit growth.

Chemicals: resilient execution in Specialty, strong momentum in Fluorochemicals

Chemicals remained SRF’s primary earnings driver. Q4 Chemicals revenue grew 3.9 percent year on year to ₹2,448.3 crore, with EBIT up 4.6 percent to ₹782.7 crore. The segment EBIT margin stayed strong at 32.0 percent. For FY26, Chemicals revenue increased 16.3 percent to ₹7,779.0 crore, and EBIT rose 35.9 percent to ₹2,262.9 crore. That pushed FY26 segment EBIT margin to 29.1 percent from 24.9 percent in FY25.

Within Chemicals, the Specialty Chemicals commentary pointed to a difficult industry setting, but also to practical execution. The company highlighted pricing pressure due to aggressive participation from Chinese players, affecting SRF’s markets as well as customers’ end markets. Yet the business delivered an improvement in Q4 over Q3 FY26, supported by cost reduction through technological intervention. Management also noted that the product pipeline has been strengthened, with customer enquiries across both Agro and Pharma segments. It also reiterated that the AI and intermediate molecules development journey remains on track.

The near-term outlook for Specialty Chemicals stays cautious. SRF expects Chinese supply to remain a key pricing factor, while geopolitical tensions and evolving U.S. tariff policies could induce volatility. Agrochemical customers continue to face pressure from generics, though demand from innovator agro majors is expected to recover gradually as conditions stabilize. In pharma, new product launches have seen initial traction, with volume ramp-up expected over the coming years. The management emphasis remains consistent: cost reduction through technology-led initiatives and operational excellence.

Fluorochemicals, in contrast, carried a more clearly positive tone. SRF reported robust performance driven by higher volumes and realizations of HFCs in domestic and exports markets, alongside steady performance in Industrial Chemicals and Fluoropolymers. It reiterated a focus on full utilization of HFC capacities. PTFE ramp-up progressed well, with key account approvals received from leading global customers.

Capex decisions in Fluorochemicals also became a defining FY26 feature. The Board approved enhancement of investment in the Odisha site to about ₹2,300 crore, covering a 20,000 MTPA HFO facility, a 30,000 MTPA new HF plant, and value-added HF derivatives. At Dahej, it approved debottlenecking capex of about ₹88 crore aligned with the company’s HCFC entitlement under the Kigali Amendment, taking HFC capacity beyond 65,000 MTPA. SRF indicated that other ongoing capex projects are progressing as planned.

The Fluorochemicals outlook is framed around stability plus selective upside. The company expects a stable demand-price environment in refrigerant gases and propellants, supported by balanced global supply-demand. It sees robust MAC demand and stable RAC demand. CMS performance is expected to remain range-bound in the near term. PTFE growth is expected to be driven by ramp-up, export mix and value-added capacity, supporting margin improvement. SRF also noted that U.S. tariff changes may provide margin support, while geopolitical volatility remains a watch item.

Performance Films and Foil: recovery signs, but capex timing turns cautious

Performance Films and Foil delivered a stronger Q4, suggesting that the worst of the recent cycle may be behind the segment. Q4 revenue increased 13.0 percent year on year to ₹1,595.6 crore, while EBIT rose 46.8 percent to ₹153.6 crore. EBIT margin improved to 9.6 percent from 7.4 percent. For FY26, revenue grew 3.8 percent to ₹5,764.2 crore, and EBIT rose 39.2 percent to ₹507.5 crore. Full-year EBIT margin improved to 8.8 percent from 6.6 percent.

Management attributed Q4 improvement to better volumes and margins in BOPET and BOPP, continued strong performance in South Africa, and improved product mix with higher exports in the Aluminum Foil business. At the same time, competitive pressures persisted in Europe, particularly in Hungary, due to low-priced imports. SRF noted that this was partly mitigated by supply disruptions linked to geopolitical factors.

A notable strategic milestone was the trial runs of the capacitor grade BOPP film line, marking entry into high-value technical films. Alongside this, SRF continued to expand sustainable product offerings and increase value-added product sales.

But the most telling signal of cycle-aware capital discipline came from the Board’s decision to defer the proposed about ₹490 crore BOPP film manufacturing facility at Indore indefinitely, citing changes in the operating environment and the need to reassess timing. For investors, this is as important as the quarterly margin recovery. It suggests management is willing to pause growth capex when returns look less attractive.

The segment outlook acknowledges that competitive pressures persist and volatility may stay elevated near term, driven by geopolitical disruptions that constrain availability of key raw materials. SRF expects China’s anti-involution measures to have a positive impact in Southeast Asian markets. Regional cues include stability in South Africa, potential improvement in Thailand margins, and logistics disruptions that could support European producers. Aluminum Foil is expected to keep gaining traction in exports, helped by customer approvals and participation in higher-value applications. Commercialization of capacitor-grade and other value-added products is positioned as the key lever for margin expansion.

Technical Textiles and Others: a margin bounce in Q4, while FY26 stays uneven

Technical Textiles had a mixed year, with Q4 showing improvement but FY26 still reflecting a weaker demand environment. Q4 segment revenue rose 5.3 percent to ₹482.5 crore, while EBIT increased 62.6 percent to ₹65.2 crore. Segment EBIT margin improved to 13.5 percent from 8.7 percent.

For FY26, Technical Textiles revenue declined 7.5 percent to ₹1,877.0 crore, and EBIT fell 20.1 percent to ₹190.1 crore. Margin moderated to 10.1 percent from 11.7 percent. Management described FY26 as a challenging operating environment, but noted that performance improved progressively through the year on stable operations.

The commentary by sub-segment gives a grounded picture of demand. Belting Fabrics saw early signs of recovery, supported by rationalization of U.S. duties that benefited customers and aided order flows. NTCF demand remained resilient, supported by growth in passenger and commercial vehicle segments, with volumes increasing modestly during the year. PIY saw healthier growth led by geo-segment demand. Across plants, SRF emphasized stability, supported by cost and efficiency initiatives.

Looking ahead, Technical Textiles faces risks from geopolitical tensions in the Middle East, which could affect input costs, logistics, and overall stability. Still, management expects gradual margin recovery in Belting Fabrics, aided by a decline in Chinese imports and improved trade tariffs for customers. NTCF demand is expected to improve with momentum in passenger and commercial vehicle segments. PIY demand is expected to remain positive, supported by the geo segment and infrastructure-linked applications.

The Others segment remained small and somewhat pressured. Q4 revenue was largely flat at ₹88.7 crore, while EBIT declined 26.3 percent to ₹9.1 crore. FY26 revenue declined 14.3 percent to ₹366.4 crore, and EBIT fell 31.7 percent to ₹47.0 crore. In Coated Fabrics, demand stayed subdued due to the off-season, but SRF said it maintained leadership in the domestic market while focusing on operational discipline and value-added products. Laminated Fabrics performance remained stable with continued focus on core applications and product mix.

What investors should take away from SRF’s FY26

SRF’s FY26 results underline a simple point: the company is gaining margin even in a mixed demand environment. Revenue growth stayed in high single digits, but EBITDA and PAT grew far faster. The Chemicals business expanded both scale and profitability, with Fluorochemicals providing a strong near-term tailwind and Specialty Chemicals holding up through cost action even as pricing pressure persisted.

The second takeaway is about capital allocation. SRF is stepping up investment in Fluorochemicals with clearly defined capacity additions in Odisha and debottlenecking at Dahej, while deferring the Indore BOPP facility indefinitely. That contrast reflects a cycle-aware approach: expand where demand-price balance and internal competitiveness look supportive, pause where the operating environment has shifted.

Third, SRF’s diversification is still working, even if earnings concentration remains high. Films showed a Q4 recovery and improved FY26 margins, while Technical Textiles improved through the year and delivered a stronger Q4 margin. Others remains small, but the company’s emphasis on operational discipline suggests a focus on defending profitability.

The theme that emerges from the presentation is disciplined execution with selective expansion. SRF is not positioning FY26 as a clean demand upcycle story. It is positioning it as a year where operational excellence, mix, and a sharper capex lens translated into higher profitability. If the company can keep ramping PTFE and deliver on value-added films while protecting Specialty Chemicals margins in a China-influenced pricing environment, the FY26 margin gains look less like a one-off and more like a base for the next phase of growth.